In Treatment of Type 2 diabetes mellitus Vilact M 850 Tablet is a combination of two medicines that work together in different ways to lower your blood glucose levels. Lowering blood glucose levels is an essential part of managing diabetes. If you can control your blood glucose level, your risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs is also lowered. Additionally, proper control of diabetes can also reduce the risk of heart disease and stroke. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using this medicine for as long as it is prescribed because it is protecting your future health.
It is unsafe to consume alcohol with Vilact M 850 Tablet.
Vilact M 850 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Vilact M 850 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Vilact M 850 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Vilact M 850 Tablet may be needed. Please consult your doctor.
Vilact M 850 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
If you miss a dose of Vilact M 850 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: USV Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Johnlee Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: B.J.Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Albia Biocare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Eris Lifesciences Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Aprica HealthCare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Novartis India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Prochem Bioceuticals Pvt. Ltd. || ₹14.5/tablet (25% cheaper)